Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
- Posted on August 12, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.